A chemical proteomic atlas of brain serine hydrolases identifies cell type-specific pathways regulating neuroinflammation

eLife

Volumn 5, Issue JANUARY2016, 2016, Pages

  Viader, Andreu ^a   Ogasawara, Daisuke ^a   Joslyn, Christopher M ^a   Sanchez Alavez, Manuel ^a   Mori, Simone ^a   Nguyen, William ^a   Conti, Bruno ^a   Cravatt, Benjamin F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOCANNABINOID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PROSTAGLANDIN SYNTHASE; PROTEOME; SERINE DEHYDRATASE; LIPOPROTEIN LIPASE; SERINE PROTEINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CELL DISRUPTION; CELLULAR DISTRIBUTION; ENZYME DEGRADATION; FLUORESCENCE; GENOTYPE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIPID METABOLISM; MICROGLIA; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OPTICAL DENSITY; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; ASTROCYTE; BRAIN; CHEMISTRY; ENZYMOLOGY; NERVE CELL; PROTEOMICS;

ANIMALS; ASTROCYTES; BRAIN; LIPOPROTEIN LIPASE; MICE; MICROGLIA; NEURONS; PROTEOMICS; SERINE ENDOPEPTIDASES;

EID: 84963525426     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.12345     Document Type: Article

References (91)

1. Aguzzi A, Barres BA, Bennett ML. 2013. Microglia: scapegoat, saboteur, or something else? Science 339:156-161. doi: 10.1126/science.1227901
2. Barres BA. 2008. The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 60: 430-440. doi: 10.1016/j.neuron.2008.10.013
3. Bélanger M, Allaman I, Magistretti PJ. 2011. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metabolism 14:724-738. doi: 10.1016/j.cmet.2011.08.016
4. Bell-Temin H, Barber DS, Zhang P, Liu B, Stevens SM. 2012. Proteomic analysis of rat microglia establishes a high-confidence reference data set of over 3000 proteins. PROTEOMICS 12:246-250. doi: 10.1002/pmic.201100398
5. Beutner C, Linnartz-Gerlach B, Schmidt SV, Beyer M, Mallmann MR, Staratschek-Jox A, Schultze JL, Neumann H. 2013. Unique transcriptome signature of mouse microglia. Glia 61:1429-1442. doi: 10.1002/glia.22524
6. Bisogno T. 2003. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. The Journal of Cell Biology 163:463-468. doi: 10.1083/jcb.200305129
7. Blankman JL, Simon GM, Cravatt BF. 2007. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chemistry & Biology 14:1347-1356. doi: 10.1016/j.chembiol.2007.11.006
8. Blankman JL, Cravatt BF. 2013. Chemical probes of endocannabinoid metabolism. Pharmacological Reviews 65: 849-871. doi: 10.1124/pr.112.006387
9. Blankman JL, Long JZ, Trauger SA, Siuzdak G, Cravatt BF. 2013. ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC. Proceedings of the National Academy of Sciences of the United States of America 110:1500-1505. doi: 10.1073/pnas.1217121110
10. Böttcher T, Sieber SA. 2008. b-lactones as privileged structures for the active-site labeling of versatile bacterial enzyme classes. Angewandte Chemie International Edition 47:4600-4603. doi: 10.1002/anie.200705768
11. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, Xing Y, Lubischer JL, Krieg PA, Krupenko SA, Thompson WJ, Barres BA. 2008. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. Journal of Neuroscience28:264-278. doi: 10.1523/JNEUROSCI.4178-07.2008
12. Chanda PK, Gao Y, Mark L, Btesh J, Strassle BW, Lu P, Piesla MJ, Zhang M-Y, Bingham B, Uveges A, Kowal D, Garbe D, Kouranova EV, Ring RH, Bates B, Pangalos MN, Kennedy JD, Whiteside GT, Samad TA. 2010. Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system. Molecular Pharmacology 78:996-1003. doi: 10.1124/mol.110.068304
13. Chang JW, Niphakis MJ, Lum KM, Cognetta AB, Wang C, Matthews ML, Niessen S, Buczynski MW, Parsons LH, Cravatt BF. 2012. Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates. Chemistry & Biology 19:579-588. doi: 10.1016/j.chembiol.2012.03.009
14. Chen R, Zhang J, Wu Y, Wang D, Feng G, Tang Y-P, Teng Z, Chen C. 2012. Monoacylglycerol lipase is a therapeutic target for alzheimer’s disease. Cell Reports 2:1329-1339. doi: 10.1016/j.celrep.2012.09.030
15. Chiu IM, Morimoto ETA, Goodarzi H, Liao JT, O’Keeffe S, Phatnani HP, Muratet M, Carroll MC, Levy S, Tavazoie S, Myers RM, Maniatis T. 2013. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Reports 4:385-401. doi: 10.1016/j.celrep.2013.06.018
16. Cravatt BF, Wright AT, Kozarich JW. 2008. Activity-based protein profiling: from enzyme chemistry to proteomic chemistry. Annual Review of Biochemistry 77:383-414. doi: 10.1146/annurev.biochem.75.101304.124125
17. Dominguez E, Galmozzi A, Chang JW, Hsu K-L, Pawlak J, Li W, Godio C, Thomas J, Partida D, Niessen S, O’Brien PE, Russell AP, Watt MJ, Nomura DK, Cravatt BF, Saez E. 2014. Integrated phenotypic and activity- based profiling links Ces3 to obesity and diabetes. Nature Chemical Biology 10:113-121. doi: 10.1038/nchembio.1429
18. Doyle JP, Dougherty JD, Heiman M, Schmidt EF, Stevens TR, Ma G, Bupp S, Shrestha P, Shah RD, Doughty ML, Gong S, Greengard P, Heintz N. 2008. Application of a translational profiling approach for the comparative analysis of CNS cell types. Cell 135:749-762. doi: 10.1016/j.cell.2008.10.029
19. Egertova M, Giang DK, Cravatt BF, Elphick MR. 1998. A new perspective on cannabinoid signalling: complimentary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proceedings of the Royal Society B: Biological Sciences 265:2081-2085. doi: 10.1098/rspb.1998.0543
20. Fiskerstrand T, Hmida-Ben Brahim D, Johansson S, M’zahem A, Haukanes BI, Drouot N, Zimmermann J, Cole AJ, Vedeler C, Bredrup C, Assoum M, Tazir M, Klockgether T, Hamri A, Steen VM, Boman H, Bindoff LA, Koenig M, Knappskog PM. 2010. Mutations in ABHD12 cause the neurodegenerative disease PHARC: an inborn error of endocannabinoid metabolism. The American Journal of Human Genetics 87:410-417. doi: 10.1016/j.ajhg.2010.08.002
21. Font-Nieves M, Sans-Fons MG, Gorina R, Bonfill-Teixidor E, Salas-Perdomo A, Marquez-Kisinousky L, Santalucia T, Planas AM. 2012. Induction of COX-2 enzyme and down-regulation of COX-1 expression by lipopolysaccharide (lPS) control prostaglandin E2 production in astrocytes. Journal of Biological Chemistry 287:6454-6468. doi: 10.1074/jbc.M111.327874
22. Fowler C, Holt S, Nilsson O, Jonsson K, Tiger G, Jacobsson S. 2005. The endocannabinoid signaling system: pharmacological and therapeutic aspects. Pharmacology Biochemistry and Behavior 81:248-262. doi: 10.1016/j.pbb.2005.01.023
23. Gao Y, Vasilyev DV, Goncalves MB, Howell FV, Hobbs C, Reisenberg M, Shen R, Zhang M-Y, Strassle BW, Lu P, Mark L, Piesla MJ, Deng K, Kouranova EV, Ring RH, Whiteside GT, Bates B, Walsh FS, Williams G, Pangalos MN, Samad TA, Doherty P. 2010. Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. Journal of Neuroscience 30:2017-2024. doi: 10.1523/JNEUROSCI.5693-09.2010
24. Glanzer JG, Enose Y, Wang T, Kadiu I, Gong N, Rozek W, Liu J, Schlautman JD, Ciborowski PS, Thomas MP, Gendelman HE. 2007. Genomic and proteomic microglial profiling: pathways for neuroprotective inflammatory responses following nerve fragment clearance and activation. Journal of Neurochemistry 102:627-645. doi: 10.1111/j.1471-4159.2007.04568.x
25. Greenbaum DC. 2002. A role for the protease falcipain 1 in host cell invasion by the human malaria parasite. Science 298:2002-2006. doi: 10.1126/science.1077426
26. Gundersen V, Storm-Mathisen J, Bergersen LH. 2015. Neuroglial transmission. Physiological Reviews 95:695-726. doi: 10.1152/physrev.00024.2014
27. Heal WP, Tate EW. 2012. Application of activity-based protein profiling to the study of microbial pathogenesis. Top Curr Chem 324:115-135. doi: 10.1007/128_2011_299
28. Hicks D, John D, Makova NZ, Henderson Z, Nalivaeva NN, Turner AJ. 2011. Membrane targeting, shedding and protein interactions of brain acetylcholinesterase. Journal of Neurochemistry 116:742-746. doi: 10.1111/j.1471-4159.2010.07032.x
29. Hoozemans JJ, Rozemuller AJ, Janssen I, De Groot CJ, Veerhuis R, Eikelenboom P. 2001. Cyclooxygenase expression in microglia and neurons in alzheimer’s disease and control brain. Acta Neuropathologica 101:2-8.
30. Hsu K-L, Tsuboi K, Adibekian A, Pugh H, Masuda K, Cravatt BF. 2012. DAGLb inhibition perturbs a lipid network involved in macrophage inflammatory responses. Nature Chemical Biology 8:999-1007. doi: 10.1038/nchembio.1105
31. Ilieva H, Polymenidou M, Cleveland DW. 2009. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. The Journal of Cell Biology 187:761-772. doi: 10.1083/jcb.200908164
32. Jessani N, Humphrey M, McDonald WH, Niessen S, Masuda K, Gangadharan B, Yates JR, Mueller BM, Cravatt BF. 2004. Carcinoma and stromal enzyme activity profiles associated with breast tumor growth in vivo. Proceedings of the National Academy of Sciences of the United States of America 101:13756-13761. doi: 10.1073/pnas.0404727101
33. Jessani N, Niessen S, Wei BQ, Nicolau M, Humphrey M, Ji Y, Han W, Noh D-Y, Yates JR, Jeffrey SS, Cravatt BF. 2005. A streamlined platform for high-content functional proteomics of primary human specimens. Nature Methods 2:691-697. doi: 10.1038/nmeth778
34. Kamat SS, Camara K, Parsons WH, Chen D-H, Dix MM, Bird TD, Howell AR, Cravatt BF. 2015. Immunomodulatory lysophosphatidylserines are regulated by ABHD16A and ABHD12 interplay. Nature Chemical Biology 11:164-171. doi: 10.1038/nchembio.1721
35. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M. 2009. Endocannabinoid-mediated control of synaptic transmission. Physiological Reviews 89:309-380. doi: 10.1152/physrev.00019.2008
36. Karlsson M, Contreras JA, Hellman U, Tornqvist H, Holm C. 1997. CDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase: Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. Journal of Biological Chemistry 272:27218-27223. doi: 10.1074/jbc.272.43.27218
37. Kettenmann H, Kirchhoff F, Verkhratsky A. 2013. Microglia: new roles for the synaptic stripper. Neuron 77:10-18. doi: 10.1016/j.neuron.2012.12.023
38. Kobe B, Kemp BE. 1999. Active site-directed protein regulation. Nature 402:373-376. doi: 10.1038/46478
39. Kohnz RA, Mulvihill MM, Chang JW, Hsu K-L, Sorrentino A, Cravatt BF, Bandyopadhyay S, Goga A, Nomura DK. 2015. Activity-based protein profiling of oncogene-driven changes in metabolism reveals broad dysregulation of PAFAH1B2 and 1B3 in cancer. ACS Chemical Biology 10:1624-1630. doi: 10.1021/acschembio.5b00053
40. Kreft M, Bak LK, Waagepetersen HS, Schousboe A. 2012. Aspects of astrocyte energy metabolism, amino acid neurotransmitter homoeostasis and metabolic compartmentation. ASN Neuro 4:187-199. doi: 10.1042/AN20120007
41. Liao L, Park SK, Xu T, Vanderklish P, Yates JR. 2008. Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice. Proceedings of the National Academy of Sciences of the United States of America 105:15281-15286. doi: 10.1073/pnas.0804678105
42. Liu Y, Patricelli MP, Cravatt BF. 1999. Activity-based protein profiling: the serine hydrolases. Proceedings of the National Academy of Sciences of the United States of America 96:14694-14699. doi: 10.1073/pnas.96.26.14694
43. Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE, Pavo´ n FJ, Serrano AM, Selley DE, Parsons LH, Lichtman AH, Cravatt BF. 2009. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nature Chemical Biology 5:37-44. doi: 10.1038/nchembio.129
44. Long JZ, Cravatt BF. 2011. The metabolic serine hydrolases and their functions in mammalian physiology and disease. Chemical Reviews 111:6022-6063. doi: 10.1021/cr200075y
45. Marrs WR, Blankman JL, Horne EA, Thomazeau A, Lin YH, Coy J, Bodor AL, Muccioli GG, Hu SS-J, Woodruff G, Fung S, Lafourcade M, Alexander JP, Long JZ, Li W, Xu C, Möller T, Mackie K, Manzoni OJ, Cravatt BF, Stella N. 2010. The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nature Neuroscience 13:951-957. doi: 10.1038/nn.2601
46. Martin R, Bajo-Graneras R, Moratalla R, Perea G, Araque A. 2015. Circuit-specific signaling in astrocyte-neuron networks in basal ganglia pathways. Science 349:730-734. doi: 10.1126/science.aaa7945
47. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, Pertwee RG, Griffin G, Bayewitch M, Barg J, Vogel Z. 1995. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochemical Pharmacology 50:83-90. doi: 10.1016/0006-2952(95)00109-D
48. Mechoulam R, Hanusˇ Lumı_r. 2000. A historical overview of chemical research on cannabinoids. Chemistry and Physics of Lipids 108:1-13. doi: 10.1016/S0009-3084(00)00184-5
49. Melchor JP, Strickland S. 2005. Tissue plasminogen activator in central nervous system physiology and pathology. Thrombosis and Haemostasis 93:655-660. doi: 10.1160/TH04-12-0838
50. Milligan ED, Watkins LR. 2009. Pathological and protective roles of glia in chronic pain. Nature Reviews Neuroscience 10:23-36. doi: 10.1038/nrn2533
51. Morrison BM, Lee Y, Rothstein JD. 2013. Oligodendroglia: metabolic supporters of axons. Trends in Cell Biology 23:644-651. doi: 10.1016/j.tcb.2013.07.007
52. Murataeva N, Straiker A, Mackie K. 2014. Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS. British Journal of Pharmacology 171:1379-1391. doi: 10.1111/bph.12411
53. Nahnsen S, Bielow C, Reinert K, Kohlbacher O. 2013. Tools for label-free peptide quantification. Molecular & Cellular Proteomics 12:549-556. doi: 10.1074/mcp.R112.025163
54. Nasheri N, Joyce M, Rouleau Y, Yang P, Yao S, Tyrrell DL, Pezacki JP. 2013. Modulation of fatty acid synthase enzyme activity and expression during hepatitis c virus replication. Chemistry & Biology 20:570-582. doi: 10.1016/j.chembiol.2013.03.014
55. Navarrete M, Araque A. 2008. Endocannabinoids mediate neuron-astrocyte communication. Neuron 57:883-893. doi: 10.1016/j.neuron.2008.01.029
56. Navarrete M, Araque A. 2010. Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes. Neuron 68:113-126. doi: 10.1016/j.neuron.2010.08.043
57. Navia-Paldanius D, Savinainen JR, Laitinen JT. 2012. Biochemical and pharmacological characterization of human alpha/beta-hydrolase domain containing 6 (aBHD6) and 12 (aBHD12). The Journal of Lipid Research 53:2413-2424. doi: 10.1194/jlr.M030411
58. Niphakis MJ, Cognetta AB, Chang JW, Buczynski MW, Parsons LH, Byrne F, Burston JJ, Chapman V, Cravatt BF. 2013. Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors. ACS Chemical Neuroscience 4:1322-1332. doi: 10.1021/cn400116z
59. Nomura DK, Long JZ, Niessen S, Hoover HS, Ng S-W, Cravatt BF. 2010. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 140:49-61. doi: 10.1016/j.cell.2009.11.027
60. Nomura DK, Morrison BE, Blankman JL, Long JZ, Kinsey SG, Marcondes MCG, Ward AM, Hahn YK, Lichtman AH, Conti B, Cravatt BF. 2011. Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science 334:809-813. doi: 10.1126/science.1209200
61. Ogasawara D, Deng H, Viader A, Baggelaar MP, Breman A, den Dulk H, van den Nieuwendijk AMCH, Soethoudt M, van der Wel T, Zhou J, Overkleeft HS, Sanchez-Alavez M, Mo S, Nguyen W, Conti B, Liu X, Chen Y, Liu Qing-song, Cravatt BF, van der Stelt M. 2016. Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition. Proceedings of the National Academy of Sciences of the United States of America 113:26-33. doi: 10.1073/pnas.1522364112
62. Pacher P. 2006. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacological Reviews 58:389-462. doi: 10.1124/pr.58.3.2
63. Patricelli MP, Giang DK, Stamp LM, Burbaum JJ. 2001. Direct visualization of serine hydrolase activities in complex proteomes using fluorescent active site-directed probes. Proteomics 1:1067-1071. doi: 10.1002/1615-9861(200109)1:9<1067::AID-PROT1067>3.0.CO;2-4
64. Phillis JW. 2005. Acetylcholine release from the central nervous system: a 50-year retrospective. Critical Reviews in Neurobiology 17:161-217. doi: 10.1615/CritRevNeurobiol.v17.i3-4.30
65. Pihlaja R, Takkinen J, Eskola O, Vasara J, López-Picón FR, Haaparanta-Solin M, Rinne JO. 2015. Monoacylglycerol lipase inhibitor JZL184 reduces neuroinflammatory response in APdE9 mice and in adult mouse glial cells. Journal of Neuroinflammation 12:81. doi: 10.1186/s12974-015-0305-9
66. Piro JR, Benjamin DI, Duerr JM, Pi Y, Gonzales C, Wood KM, Schwartz JW, Nomura DK, Samad TA. 2012. A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of alzheimer’s disease. Cell Reports 1:617-623. doi: 10.1016/j.celrep.2012.05.001
67. Reisenberg M, Singh PK, Williams G, Doherty P. 2012. The diacylglycerol lipases: structure, regulation and roles in and beyond endocannabinoid signalling. Philosophical Transactions of the Royal Society B: Biological Sciences 367:3264-3275. doi: 10.1098/rstb.2011.0387
68. Romanovsky AA. 2004. Do fever and anapyrexia exist? analysis of set point-based definitions. AJP: Regulatory, Integrative and Comparative Physiology 287:R992-R995. doi: 10.1152/ajpregu.00068.2004
69. Sanchez-Alavez M, Nguyen W, Mori S, Moroncini G, Viader A, Nomura DK, Cravatt BF, Conti B, Rubino T. 2015. Monoacylglycerol lipase regulates fever response. PLOS ONE 10:e0134437. doi: 10.1371/journal.pone.0134437
70. Schlosburg JE, Blankman JL, Long JZ, Nomura DK, Pan B, Kinsey SG, Nguyen PT, Ramesh D, Booker L, Burston JJ, Thomas EA, Selley DE, Sim-Selley LJ, Liu Qing-song, Lichtman AH, Cravatt BF. 2010. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nature Neuroscience 13:1113-1119. doi: 10.1038/nn.2616
71. Schwanhäusser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W, Selbach M. 2011. Global quantification of mammalian gene expression control. Nature 473:337-342. doi: 10.1038/nature10098
72. Sharma K, Schmitt S, Bergner CG, Tyanova S, Kannaiyan N, Manrique-Hoyos N, Kongi K, Cantuti L, Hanisch U-K, Philips M-A, Rossner MJ, Mann M, Simons M. 2015. Cell type- and brain region-resolved mouse brain proteome. Nature Neuroscience 18:1819-1831. doi: 10.1038/nn.4160
73. Sheridan C. 2009. Glial cells on the radar. Nature Biotechnology 27:114-116. doi: 10.1038/nbt0209-114
74. Shonesy BC, Bluett RJ, Ramikie TS, Báldi R, Hermanson DJ, Kingsley PJ, Marnett LJ, Winder DG, Colbran RJ, Patel S. 2014. Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation. Cell Reports 9:1644-1653. doi: 10.1016/j.celrep.2014.11.001
75. Siegel G, Obernosterer G, Fiore R, Oehmen M, Bicker S, Christensen M, Khudayberdiev S, Leuschner PF, Busch CJL, Kane C, Hübel K, Dekker F, Hedberg C, Rengarajan B, Drepper C, Waldmann H, Kauppinen S, Greenberg ME, Draguhn A, Rehmsmeier M, Martinez J, Schratt GM. 2009. A functional screen implicates microRNA-138- dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nature Cell Biology 11:705-716. doi: 10.1038/ncb1876
76. Simon GM, Cravatt BF. 2010. Activity-based proteomics of enzyme superfamilies: serine hydrolases as a case study. Journal of Biological Chemistry 285:11051-11055. doi: 10.1074/jbc.R109.097600
77. Skorko-Glonek J, Zurawa-Janicka D, Koper T, Jarzab M, Figaj D, Glaza P, Lipinska B. 2012. HtrA protease family as therapeutic targets. Current Pharmaceutical Design 19:977-1009. doi: 10.2174/1381612811319060003
78. Soberman RJ, Christmas P. 2003. The organization and consequences of eicosanoid signaling. Journal of Clinical Investigation 111:1107-1113. doi: 10.1172/JCI200318338
79. Sontag E, Nunbhakdi-Craig V, Sontag J-M, Diaz-Arrastia R, Ogris E, Dayal S, Lentz SR, Arning E, Bottiglieri T. 2007. Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation. Journal of Neuroscience 27:2751-2759. doi: 10.1523/JNEUROSCI.3316-06.2007
80. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K. 1995. 2-arachidonoylgylcerol: a possible endogenous cannabinoid receptor ligand in brain. Biochemical and Biophysical Research Communications 215:89-97. doi: 10.1006/bbrc.1995.2437
81. Sugiura T, Kishimoto S, Oka S, Gokoh M. 2006. Biochemistry, pharmacology and physiology of 2- arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Progress in Lipid Research 45:405-446. doi:10.1016/j.plipres.2006.03.003
82. Tanimura A, Yamazaki M, Hashimotodani Y, Uchigashima M, Kawata S, Abe M, Kita Y, Hashimoto K, Shimizu T, Watanabe M, Sakimura K, Kano M. 2010. The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase a mediates retrograde suppression of synaptic transmission. Neuron 65:320-327. doi: 10.1016/j.neuron.2010.01.021
83. Tanimura A, Uchigashima M, Yamazaki M, Uesaka N, Mikuni T, Abe M, Hashimoto K, Watanabe M, Sakimura K, Kano M. 2012. Synapse type-independent degradation of the endocannabinoid 2-arachidonoylglycerol after retrograde synaptic suppression. Proceedings of the National Academy of Sciences of the United States of America 109:12195-12200. doi: 10.1073/pnas.1204404109
84. Tsou K, Nogueron MI, Muthian S, Sañudo-Peña MC, Hillard CJ, Deutsch DG, Walker JM. 1998. Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry Neuroscience Letters 254:137-140. doi: 10.1016/S0304-3940(98)00700-9
85. Viader A, Blankman JL, Zhong P, Liu X, Schlosburg JE, Joslyn CM, Liu Q-S, Tomarchio AJ, Lichtman AH, Selley DE, Sim-Selley LJ, Cravatt BF. 2015. Metabolic interplay between astrocytes and neurons regulates endocannabinoid action. Cell Reports 12:798-808. doi: 10.1016/j.celrep.2015.06.075
86. Wallingford N, Perroud B, Gao Q, Coppola A, Gyengesi E, Liu ZW, Gao XB, Diament A, Haus KA, Shariat-Madar Z, Mahdi F, Wardlaw SL, Schmaier AH, Warden CH, Diano S. 2009. Prolylcarboxypeptidase regulates food intake by inactivating alpha-MSH in rodents. The Journal of Clinical Investigation 119:2291-2303. doi: 10.1172/JCI37209
87. Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G, Mackie K, Stella N. 2003. Nonpsychotropic cannabinoid receptors regulate microglial cell migration. The Journal of Neuroscience 23:1398-1405.
88. Washburn MP, Wolters D, Yates JR. 2001. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nature Biotechnology 19:242-247. doi: 10.1038/85686
89. Yang J-W, Rodrigo R, Felipo V, Lubec G. 2005. Proteome analysis of primary neurons and astrocytes from rat cerebellum. Journal of Proteome Research 4:768-788. doi: 10.1021/pr049774v
90. Yu L-R. 2004. Global analysis of the cortical neuron proteome. Molecular & Cellular Proteomics 3:896-907. doi: 10.1074/mcp.M400034-MCP200
91. Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O’Keeffe S, Phatnani HP, Guarnieri P, Caneda C, Ruderisch N, Deng S, Liddelow SA, Zhang C, Daneman R, Maniatis T, Barres BA, Wu JQ. 2014. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. Journal of Neuroscience 34:11929-11947. doi: 10.1523/JNEUROSCI.1860-14.2014